Discussing GSK's plans to reinvest 20% of its profits from less developed countries to improve health care; global opportunities, and new growth models, with Andrew Witty, GlaxoSmithKline CEO
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT